Status: Recruiting
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).
Participants needed: 90
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Jazz PharmaceuticalsUpdated: Jun 10, 2026Locations: 9
Eligibility criteria
Has histologically confirmed pheochromocytoma or paraganglioma that is unresecta... [+9]
Has known hypersensitivity to ONC206 or any excipient used in the ONC206 study t... [+11]